 the Private Securities Litigation Reform Act of 0000. COVID-00, the collaboration between BioNTech and its collaborators are developing multiple mRNA vaccine program will be satisfied with the U. About BioNTech Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other potential vaccines that may arise from the BNT000 